The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy

The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy

Detalhes bibliográficos
Main Authors:	Fokas, E, Prevo, R, Reaper, P, Charlton, P, Pollard, J, Mckenna, W, Muschel, R, Brunner, T
Formato:	Conference item
Publicado em:	2012

Registos relacionados

The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.
Por: Prevo, R, et al.
Publicado em: (2012)

ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
Por: Fokas, E, et al.
Publicado em: (2013)

Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
Por: Fokas, E, et al.
Publicado em: (2012)

Targeting ATR in DNA damage response and cancer therapeutics.
Por: Fokas, E, et al.
Publicado em: (2014)

Targeting ATR in DNA damage response and cancer therapeutics
Por: Fokas, E, et al.
Publicado em: (2014)

The ATR inhibitor VE-821 increases the sensitivity of gastric cancer cells to cisplatin
Por: Haochen Su, et al.
Publicado em: (2023-10-01)

Targeting radiation-resistant hypoxic tumour cells through ATR inhibition.
Por: Pires, I, et al.
Publicado em: (2012)

Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
Por: Pires, I, et al.
Publicado em: (2012)

Farnesyltransferase inhibitors as radiation sensitizers.
Por: Brunner, T, et al.
Publicado em: (2003)

Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells.
Por: Barbora Šalovská, et al.
Publicado em: (2018-01-01)

Farnesyltransferase inhibitors as radiation sensitizers.
Por: Mckenna, W, et al.
Publicado em: (2002)

The use of signal transduction inhibitors with radiation
Por: Mckenna, W, et al.
Publicado em: (2006)

NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity.
Por: Fokas, E, et al.
Publicado em: (2012)

Targeting tumor cells by enhancing radiation sensitivity.
Por: Mckenna, W, et al.
Publicado em: (2003)

Targeting the PI3K/mTOR and ATR/Chk1 pathways to improve radiation efficacy for cancer therapy
Por: Fokas, E
Publicado em: (2012)

Die hard? Radiation sensitivity of cancer stem cells from established human cell lines
Por: Brunner, T, et al.
Publicado em: (2009)

ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
Por: Chris T. Williamson, et al.
Publicado em: (2016-12-01)

The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies.
Por: Fokas, E, et al.
Publicado em: (2012)

The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies
Por: Fokas, E, et al.
Publicado em: (2012)

The Interaction of pancreatic Cancer and Stellate Cells as a Mediator of Radiation Resistance in ductal Pancreatic Adenocarcinoma
Por: Mantoni, T, et al.
Publicado em: (2011)

Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
Por: Kumar Sanjiv, et al.
Publicado em: (2016-12-01)

Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic.
Por: Fokas, E, et al.
Publicado em: (2015)

High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML
Por: Yue Zhao, et al.
Publicado em: (2016-08-01)

The radiation response of cancer stem cells from established human cell lines
Por: Al-Assar, O, et al.
Publicado em: (2009)

Farnesyltransferase inhibitors as radiation sensitizers
Por: Mckenna, W
Publicado em: (2005)

The Radiation Response of Cancer Stem Cell-like Subpopulations from Established Human Cell Lines
Por: Brunner, T, et al.
Publicado em: (2009)

Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.
Por: Brunner, T, et al.
Publicado em: (2003)

Radiation response of cancer stem-like cells from established human cell lines after sorting for surface markers.
Por: Al-Assar, O, et al.
Publicado em: (2009)

Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1.
Por: Cordes, N, et al.
Publicado em: (2007)

A comparison of four target volume definitions for pancreatic cancer: Two concepts including the lymphatics (RTOG and German multi-centre neoadjuvant trial) and two concepts only treating the primary tumour (Michigan and UK-SCALOP)
Por: Fokas, E, et al.
Publicado em: (2012)

NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity
Por: Fokas Emmanouil, et al.
Publicado em: (2012-03-01)

The RAS signal transduction pathway and its role in radiation sensitivity.
Por: Mckenna, W, et al.
Publicado em: (2003)

Investigating resistance mechanisms to ATR inhibitors
Por: Olyha, S
Publicado em: (2016)

Leucemia mielóide aguda t(8;21): freqüência em pacientes brasileiros Acute myeloid leukemia with t(8;21): frequency among Brazilians
Por: Maria de Lourdes L. F. Chauffaille, et al.
Publicado em: (2004-01-01)

8.21 The Physics of Energy, Fall 2008
Por: Jaffe, Robert L., et al.
Publicado em: (2008)

EWD821: From Predicate Transformers to Predicates
Por: Dijkstra, E
Publicado em: (2015)

SENTENCIA ROL N° 11.821 - 2003
Publicado em: (2003-01-01)

Knockdown of the integral membrane protein caveolin-1 sensitizes human pancreatic carcinoma cells to ionizing radiation
Por: Cordes, N, et al.
Publicado em: (2008)

Prospects for the Use of ATR Inhibitors to Treat Cancer
Por: Scott H. Kaufmann, et al.
Publicado em: (2010-04-01)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
Por: Wang, L, et al.
Publicado em: (2015)